These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 33188581)

  • 1. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
    Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
    Geerlinks AV; Abla O
    Paediatr Drugs; 2023 Jul; 25(4):399-409. PubMed ID: 37204611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed histiocytic disorders: Nature versus nurture?
    McClain K; Dimitrion P
    Br J Haematol; 2024 Jul; 205(1):20-21. PubMed ID: 38763166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological Manifestations of Histiocytic Disorders.
    Banks SA; Sartori Valinotti JC; Go RS; Abeykoon JP; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Bennani NN; Shah MV; Rech KL; Tobin WO;
    Curr Neurol Neurosci Rep; 2023 Jun; 23(6):277-286. PubMed ID: 37209319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking.
    Gallego CT; Bueno J; Cruces E; Stelow EB; Mancheño N; Flors L
    Radiologia (Engl Ed); 2019; 61(3):215-224. PubMed ID: 30686482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].
    Bösmüller H; Nann D; Horger M; Fend F
    Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
    Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined histiocytosis of the Langerhans group (Langerhans cell histiocytosis and Erdheim-Chester disease) in a 64-year-old man with BRAF and NRAS mutations: a case report].
    Rodríguez-Duque MS; Martín Soler P; González Vela MC; Gómez Román JJ
    Rev Esp Patol; 2023; 56(3):186-190. PubMed ID: 37419557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease.
    Conley A; Manjila S; Guan H; Guthikonda M; Kupsky WJ; Mittal S
    Neuropathology; 2010 Dec; 30(6):634-47. PubMed ID: 20337948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
    Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
    J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review.
    Aouba A; Larousserie F; Le Guern V; Martin A; Guillevin L
    Joint Bone Spine; 2009 Dec; 76(6):701-4. PubMed ID: 19640768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
    Friedman JS; Durham BH; Reiner AS; Yabe M; Petrova-Drus K; Dogan A; Pulitzer M; Busam KJ; Francis JH; Rampal RK; Ulaner GA; Reddy R; Yeh R; Hatzoglou V; Lacouture ME; Rotemberg V; Mazor RD; Hershkovitz-Rokah O; Shpilberg O; Goyal G; Go RS; Abeykoon JP; Rech K; Morlote D; Fidai S; Gannamani V; Zia M; Abdel-Wahab O; Panageas KS; Rosenblum MK; Diamond EL
    Br J Haematol; 2024 Jul; 205(1):127-137. PubMed ID: 38613141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
    Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
    Salama HA; Jazieh AR; Alhejazi AY; Absi A; Alshieban S; Alzahrani M; Alaskar A; Gmati G; Damlaj M; Abuelgasim KA; Alghamdi A; Alahmari B; Almugairi A; Alzahrani H; Bazarbachi A; Musa MOH; Goyal G
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e66-e75. PubMed ID: 32943371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases.
    O'Malley DP; Duong A; Barry TS; Chen S; Hibbard MK; Ferry JA; Hasserjian RP; Thompson MA; Richardson MS; Jaffe R; Sidhu JS; Banks PM
    Mod Pathol; 2010 Dec; 23(12):1616-23. PubMed ID: 20729813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCT2 expression in histiocytoses.
    Ungureanu IA; Cohen-Aubart F; Héritier S; Fraitag S; Charlotte F; Lequain H; Hélias-Rodzewicz Z; Haroche J; Donadieu J; Emile JF
    Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
    Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y
    J Neurosurg Pediatr; 2019 Jan; 23(1):48-53. PubMed ID: 30265230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I Diagnose Rosai-Dorfman Disease.
    Ravindran A; Rech KL
    Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib.
    Portegys J; Heidemeier A; Rosenwald A; Gernert M; Fröhlich M; Hueper S; Strunz PP; Rasche L; Schmalzing M
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36693681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.